All In Biotech

Drug Trial Radar · NCT04184622

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)

Last checked: Nov 20, 2026Latest source record: Jul 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,539 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,539

Actual

Start

Dec 4, 2019

Primary completion

Apr 1, 2022

Study completion Jul 6, 2024

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Dec 3, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weight. The study has two phases: A main phase and an extension phase. The main phase of the study will last 72 weeks. Participants with prediabetes will continue in the extension for another 2 years.

Conditions

  • Overweight
  • Obesity

Interventions

  • TirzepatideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in Body Weight (Primary Treatment Period)Time frame: Baseline, Week 72
  2. Percentage of Participants Who Achieve ≥5% Body Weight Reduction (Primary Treatment Period)Time frame: Week 72

Locations

118 sites in 10 countries. Site status is shown where the registry gives one.

  • Cahaba Research

    Pelham, Alabama

  • Perseverance Research Center

    Scottsdale, Arizona

  • John Muir Physician Network Clinical Research Center

    Concord, California

  • Valley Research

    Fresno, California

  • National Research Institute - Wilshire

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Encompass Clinical Research

    Spring Valley, California

  • University Clinical Investigators, Inc.

    Tustin, California

  • Yale University School of Medicine

    New Haven, Connecticut

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Suncoast Research Group

    Miami, Florida

  • New Horizon Research Center

    Miami, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Oviedo Medical Research

    Oviedo, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Center for Advanced Research & Education

    Gainesville, Georgia

  • Herman Clinical Research

    Suwanee, Georgia

  • SKY Integrative Medical Center/SKYCRNG

    Union City, Georgia

  • East-West Medical Research Institute

    Honolulu, Hawaii

  • Midwest Institute for Clinical Research

    Indianapolis, Indiana

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas

  • L-MARC Research Center

    Louisville, Kentucky

  • NECCR PrimaCare Research

    Fall River, Massachusetts

  • ActivMed Practices and Research

    Methuen, Massachusetts

  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division

    Troy, Michigan

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Clinvest Research LLC

    Springfield, Missouri

  • Palm Research Center Sunset

    Las Vegas, Nevada

  • Premier Research

    Trenton, New Jersey

  • NYU Langone Health

    New York, New York

  • Weill Cornell Medical College

    New York, New York

  • Rochester Clinical Research, LLC

    Rochester, New York

  • University of North Carolina Medical Center

    Chapel Hill, North Carolina

  • PharmQuest

    Greensboro, North Carolina

  • Lillestol Research

    Fargo, North Dakota

  • Velocity Clinical Research, Cleveland

    Cleveland, Ohio

  • Aventiv Research Inc

    Columbus, Ohio

  • Alliance for Multispecialty Research, LLC

    Norman, Oklahoma

  • Summit Research Network

    Portland, Oregon

Showing 40 of 118 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.